The diagnosis of anxiety disorders and major depression can be reliably mad
e based on signs and symptoms. However there are significant limitations to
the current system of classification including overlapping criteria, high
comorbidity, and the issue of subthreshold syndromes. The literature on tre
atment response documents that selective serotonin reuptake inhibitors are
effective in the treatment of the various anxiety disorders, including when
comorbid major depression is present. The literature also suggests that tr
icyclic antidepressant medications have superior benefits over selective se
rotonin reuptake inhibitors in major depression. Examination of the functio
nal anatomy of the fear and reward systems may shed light on the underlying
processes in the anxiety and depressive disorders. Such an approach points
out the importance of addressing avoidance behaviors, which may be more re
sponsive to cognitive behavioral treatments than pharmacological agents. (C
) 2001 Wiley-Liss, Inc.